STOCK TITAN

Avanos Medical Stock Price, News & Analysis

AVNS NYSE

Company Description

Company Overview

Avanos Medical, Inc. (NYSE: AVNS) is a United States-based medical technology company that focuses on delivering clinically superior medical device solutions. With a clear commitment to addressing critical healthcare needs such as pain management, recovery, and digestive health, the company leverages breakthrough technologies that aid patients in returning to the activities that matter most. By integrating state-of-the-art innovation and robust patient-centric solutions, Avanos Medical stands as a noteworthy participant in the rapidly evolving field of medical device innovation.

Core Business Areas

At its core, Avanos Medical specializes in the development, manufacturing, and marketing of advanced therapeutic devices. The company has refined its commercial operations by combining its Chronic Care and Pain Management franchises into a structured commercial organization centered on two primary divisions:

  • Digestive Health: This division emphasizes life-sustaining nutritional support by providing essential solutions such as neonatal and pediatric feeding systems. Products in this category are designed to offer enhanced safety and efficacy from hospital to home.
  • Pain Management and Recovery: Focused on non-opioid therapeutic alternatives, this segment includes innovative cold compression systems and infusion devices that deliver precise pain management. These solutions are tailored to reduce opioid reliance while supporting patient recovery post-surgery and in chronic care settings.

Innovation and Transformation

Avanos Medical is undergoing a significant transformation designed to refine its product portfolio and enhance operational efficiency. This transformation involves:

  • Investing in breakthrough technologies that improve clinical outcomes.
  • Enhancing manufacturing processes to ensure high-quality standards.
  • Streamlining operations by integrating product categories and reducing redundancies.
  • Strengthening its competitive positioning by focusing on non-opioid therapies and recovery technologies.

The company’s focus on innovative design and efficient production is evident in its recent launch of advanced solutions such as improved feeding tube retention systems and state-of-the-art recovery technologies. These developments underscore Avanos Medical's commitment to clinical excellence and the continuous advancement of patient care solutions.

Global Market Position and Reach

Headquartered in Alpharetta, Georgia, Avanos Medical operates on a global scale, marketing its recognized brands across more than 90 countries. Its expansive distribution network and strong relationships with healthcare providers reinforce its position as a major player in the medical device industry. The company’s ability to adapt to different healthcare environments and regulatory requirements underlines its expertise and commitment to patient safety and quality of care.

Patient-Centric Solutions and Industry Impact

Avanos Medical’s solutions are engineered with the patient in mind. By targeting key healthcare challenges—such as reducing the use of opioids and enhancing recovery processes—the company not only meets clinical needs but also contributes to broader public health objectives. In an industry where treatment efficacy and patient safety are paramount, Avanos Medical’s focus on non-opioid pain management and innovative nutritional support provides clear benefits that resonate across healthcare settings.

Technological Capabilities and Product Portfolio

A significant aspect of Avanos Medical’s strategy involves integrating advanced technology into its product offerings. The company employs innovative systems such as cold compression therapy and combination modalities that merge traditional techniques with new technological advancements. These comprehensive solutions are designed to:

  • Support recovery faster and more effectively.
  • Ensure consistent and accurate delivery of treatment.
  • Enhance clinical performance and patient safety.

This focus on technological integration not only highlights the company’s commitment to research and development but also reinforces its authoritative standing in an increasingly competitive market.

Operational Excellence and Strategic Transformation

The company continues to streamline its business operations under a clearly articulated transformation initiative. By consolidating product portfolios and focusing on its core segments, Avanos Medical aims to optimize operational performance while mitigating risks associated with market fluctuations. Emphasis on cost-management, disciplined spending, and transformational process improvements has been instrumental in securing its competitive edge.

Competitive Landscape

Within the broader medical device industry, Avanos Medical differentiates itself through:

  • A focus on clinically validated, non-opioid treatment alternatives.
  • Strong global brand recognition and extensive market reach.
  • An evolving portfolio that addresses both immediate and long-term healthcare challenges.

The company’s strategic decision to concentrate on high-impact areas such as digestive health and pain management enables it to navigate competitive pressures while continuing to innovate.

Conclusion

In summary, Avanos Medical is a prominent medical technology company committed to delivering breakthrough solutions that address critical healthcare needs. From its patient-centric approach and innovative technological applications to its expansive global operations and focused transformation initiatives, the company demonstrates a robust operational framework and deep industry expertise. Whether through advanced pain management systems or essential nutritional support solutions, Avanos Medical’s offerings are designed to improve clinical outcomes and elevate the standard of patient care worldwide.

Stock Performance

$—
0.00%
0.00
Last updated:
-29.81 %
Performance 1 year
$555.7M
Market Cap
46.0M
Shares outstanding

SEC Filings

No SEC filings available for Avanos Medical.

Financial Highlights

$687,800,000
Revenue (TTM)
-$392,100,000
Net Income (TTM)
-$8.53
Diluted EPS (TTM)
$100,700,000
Operating Cash Flow
-57.01%
Net Profit Margin
-57.60%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Avanos Medical (AVNS)?

The current stock price of Avanos Medical (AVNS) is $12.71 as of April 29, 2025.

What is the market cap of Avanos Medical (AVNS)?

The market cap of Avanos Medical (AVNS) is approximately 555.7M.

What is the revenue (TTM) of Avanos Medical (AVNS) stock?

The trailing twelve months (TTM) revenue of Avanos Medical (AVNS) is $687,800,000.

What is the net income of Avanos Medical (AVNS)?

The trailing twelve months (TTM) net income of Avanos Medical (AVNS) is -$392,100,000.

What is the earnings per share (EPS) of Avanos Medical (AVNS)?

The diluted earnings per share (EPS) of Avanos Medical (AVNS) is -$8.53 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Avanos Medical (AVNS)?

The operating cash flow of Avanos Medical (AVNS) is $100,700,000.

What is the profit margin of Avanos Medical (AVNS)?

The net profit margin of Avanos Medical (AVNS) is -57.01%.

What is the operating margin of Avanos Medical (AVNS)?

The operating profit margin of Avanos Medical (AVNS) is -57.60%.

What is the gross margin of Avanos Medical (AVNS)?

The gross profit margin of Avanos Medical (AVNS) is 55.44%.

What is the current ratio of Avanos Medical (AVNS)?

The current ratio of Avanos Medical (AVNS) is 2.37, indicating the company's ability to pay short-term obligations.

What is the gross profit of Avanos Medical (AVNS)?

The gross profit of Avanos Medical (AVNS) is $381,300,000 on a trailing twelve months (TTM) basis.

What is the operating income of Avanos Medical (AVNS)?

The operating income of Avanos Medical (AVNS) is -$396,200,000.

What does Avanos Medical do?

Avanos Medical develops, manufactures, and markets innovative medical device solutions focused on pain management, recovery, and digestive health. Their products help patients transition from hospital care to recovery while addressing key clinical needs.

What are the core business areas of Avanos Medical?

The company primarily concentrates on two main segments: Digestive Health, which includes essential nutritional support systems, and Pain Management and Recovery, which features non-opioid, innovative pain therapies and recovery technologies.

How does Avanos Medical maintain its competitive edge in the industry?

Avanos Medical focuses on continuous innovation, integrating advanced technologies into its products, streamlining operations through a comprehensive transformation process, and ensuring global distribution across diverse healthcare markets.

What technologies or therapies is Avanos Medical known for?

The company is recognized for its breakthrough solutions such as advanced cold compression systems, innovative feeding tube retention systems, and infusion devices that deliver non-opioid pain management therapies.

In which markets does Avanos Medical operate?

Headquartered in the United States, Avanos Medical markets its products globally in more than 90 countries, serving diverse healthcare systems and meeting the needs of various patient populations.

How does Avanos Medical address patient safety and recovery?

Through its focus on clinically superior and patient-focused solutions, Avanos Medical designs products that enhance recovery outcomes and reduce reliance on opioids, ensuring safer and more effective patient care.

What is the significance of the company’s transformation process?

The transformation initiative is aimed at consolidating product portfolios, improving operational efficiency, and strategically positioning Avanos Medical to better serve its target markets in both digestive health and pain management.

How do Avanos Medical's products contribute to reducing opioid usage?

By offering innovative, non-opioid therapeutic solutions and advanced recovery systems, the company provides effective alternatives to opioid-based pain management, supporting safer recovery processes for patients.